menu

Quintiles Library

Show Filters
Presentation
ISPOR EU Presentation: Indirect Social Cost of Multiple Sclerosis, Results from ROBUST
Explore more
Presentation
Presentations from ISPOR EU Workshop on The Role of Patient Registries in Evidence Development: Similarities and Difference Between Europe and North America Eric Gemmen, MA, Quintiles Late Phase
Explore more
Fact Sheet
Quintiles’ Interactive Response Technology (IRT) platform SEAMLESSLY integrates patient interaction systems for clinical development with the supply chain services of clinical labeling, packaging and distribution.Quintiles’ Interactive Response Technology (IRT) platform SEAMLESSLY integrates patient interaction systems for clinical development with the supply chain...
Read more
White Paper
A summary of key insights exchanged between pharma executives at the inaugural Quintiles Consulting Executive Vision Forum.
Explore here
Media Coverage
Jim Kirk, Practice Leader for Quintiles Consulting’s Market Intelligence Practice has received the President’s Award from the Pharmaceutical Marketing Research Group (PMRG). The award was presented during PMRG’s recent annual meeting in Philadelphia.
Read more
Media Coverage
As payers balk at rising drug prices and patent expirations threaten the industry’s revenue streams, pharmaceutical companies worldwide are looking for ways to cut costs associated with drug development and, simultaneously, speed the process up. It might seem natural to focus first on phase III trials, where the bulk of development costs are incurred. But in many cases...
Read more
Fact Sheet
Learn more about Quintiles’ Market Intelligence and Analytics consulting solution. Learn more about Quintiles’ Market Intelligence and Analytics consulting solution.
Read more
Presentation
Murtuza Burhmal, Associate Director, Medical Affairs, Epidemiology and Outcomes Research Health and Quality of Life Outcomes, 2009
Explore more
Press Release
RESEARCH TRIANGLE PARK, N.C. – November 6, 2009 – To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in...
Read More
Presentation
Shilpa Viswanathan, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting
Explore more
Press Release
Quintiles Executive Vice President and Chief Information Officer (CIO) William “Bill” Deam has been named to the “CIO Hall of Fame” which selects honorees for their leadership in the CIO community and contributions to the advancement of the profession. Bill Deam is responsible for Quintiles’ IT organization in nearly 60 countries around the world and has expanded his role...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – November 2, 2009 – Quintiles today announced that it has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe. As a result of the alliance, Quintiles will assume the operational responsibilities for the...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – October 30, 2009 – Quintiles today announced a strategic alliance with leading global pharmaceutical company Eisai Co., Ltd. (Tokyo, Japan) to develop six potential oncology products in Eisai’s R&D pipeline. Under the terms of the agreement, Quintiles’ oncology experts will conduct Phase II proof-of-concept studies for 11 solid tumor...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – October 29, 2009 – Quintiles Consulting today announced three key appointments in its US Regulatory and Quality consulting practice. These new appointments expand Quintiles’ experience in regulatory compliance and quality system development. They also bring industry-leading expertise to the table to help clients navigate a rapidly changing...
Read More
Press Release
LONDON, ENGLAND – 26 October 2009 – A significant step in driving innovation, improving patient care and increasing efficiency in early stage clinical research was taken today with the announcement that two of the UK’s leading institutions - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London - have signed a collaborative agreement with Quintiles, the only...
Read More
Presentation
ISPOR EU 2009 Poster: "The Relationship Between Drug Utilization and Out of Pocket Expenses.
Explore more
Press Release
RESEARCH TRIANGLE PARK, N.C. – October 21, 2009 – In a new report released today, John Doyle, Vice President and Practice Leader for Quintiles Consulting, and an expert on pharmaceutical market access, explores the complex issue of comparative effectiveness research (CER) and its strategic importance in successful and efficient biopharmaceutical development. The report...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C., and KANSAS CITY, Mo. – October 1, 2009 – Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, and Cerner, a global supplier of healthcare solutions and electronic health record (EHR) technology, today announced an agreement that will provide...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – September 30, 2009 – Patients who want to play an active role in bringing new, safer drugs to market faster now have access to a global Web site that makes it easier than ever before to identify clinical trials to participate in – regardless of geography or the drug company sponsor. The new Web site, www.clinicalresearch.com, presents...
Read More
Press Release
BRACKNELL, UK and BURTON-UPON-TRENT, UK – 29 September 2009 – Innovex, a Quintiles company, and Healthcare at Home today announced that they have agreed to form an innovative healthcare joint venture in Europe, named Healthcare at Home Europe. Healthcare at Home Europe, a separate legal entity run by its own management board, will develop homecare services, allowing...
Read More